| Literature DB >> 32117361 |
Ning Zhang1, Holly M Roberts1, Joyce Van Eck1,2, Gregory B Martin1,3.
Abstract
The CRISPR/Cas9 system is a powerful tool for targeted gene editing in many organisms including plants. However, most of the reported uses of CRISPR/Cas9 in plants have focused on modifying one or a few genes, and thus the overall specificity, types of mutations, and heritability of gene alterations remain unclear. Here, we describe the molecular characterization of 361 T0 transgenic tomato plants that were generated using CRISPR/Cas9 to induce mutations in 63 immunity-associated genes. Among the T0 transformed plants, 245 carried mutations (68%), with 20% of those plants being homozygous for the mutation, 30% being heterozygous, 32% having two different mutations (biallelic), and 18% having multiple mutations (chimeric). The mutations were predominantly short insertions or deletions, with 87% of the affected sequences being smaller than 10 bp. The majority of 1 bp insertions were A (50%) or T (29%). The mutations from the T0 generation were stably transmitted to later generations, although new mutations were detected in some T1 plants. No mutations were detected in 18 potential off-target sites among 144 plants. Our study provides a broad and detailed view into the effectiveness of CRISPR/Cas9 for genome editing in an economically important plant species.Entities:
Keywords: CRISPR/Cas9; Off-target mutation; genome editing; immunity-associated genes; tomato
Year: 2020 PMID: 32117361 PMCID: PMC7010635 DOI: 10.3389/fpls.2020.00010
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Mutation rates and mutation types in T0 transgenic plants. See also .
| Target genes | Solyc # | # of transgenic plants | # of edited plants | Mutation rate (%)a | Mutation typesb |
|---|---|---|---|---|---|
| ADE | Solyc05g005700 | 10 | 5 | 50 | 3 homo; 1 hetero; 1 chimeric |
| AOX | Solyc08g075550 | 9 | 8 | 89 | 2 homo; 2 biallelic; 3 hetero; 2 chimeric |
| APE | Solyc11g018800 | 1 | 1 | 100 | 1 biallelic |
| Aquaporin 1/2/3 | Solyc11g069430 (Aquaporin 1) | 12 | 10 | 83 | 5 homo; 2 biallelic; 10 hetero; 2 chimeric |
| Solyc06g074820 (Aquaporin 2) | |||||
| Solyc08g066840 (Aquaporin 3) | |||||
| BHLH | Solyc03g114230 | 3 | 3 | 100 | 3 biallelic |
| BSK830 | Solyc12g099830 | 8 | 6 | 75 | 2 biallelic; 3 hetero; 1 chimeric |
| BSK830 (Hawaii 7981) | Solyc12g099830 | 6 | 5 | 83 | 3 biallelic; 1 hetero; 1 chimeric |
| Bti9-interactor | Solyc09g008010 | 1 | 1 | 100 | 1 homo |
| Bti9ab | Solyc07g049180 | 4 | 3 | 75 | 2 homo; 1 biallelic |
| CathepsinB1 | Solyc02g076980 | 29 | 20 | 69 | 8 homo; 8 biallelic; 2 hetero; 2 chimeric |
| CathepsinB2 | Solyc02g077040 | 11 | 8 | 73 | 2 homo; 3 biallelic; 3 hetero |
| CORE | Solyc03g096190 | 7 | 6 | 86 | 1 homo; 4 biallelic; 1 hetero |
| Drm-3 | Solyc01g099840 | 3 | 3 | 100 | 2 biallelic; 1 hetero |
| EDS1 | Solyc06g071280 | 2 | 2 | 100 | 1 homo; 1 chimeric |
| ERF5 | Solyc03g093560 | 7 | 5 | 71 | 2 biallelic; 1 hetero; 2 chimeric |
| Fen | Solyc05g013290 | 18 | 13 | 72 | 5 biallelic; 7 hetero; 1 chimeric |
| Fen (RG-pto11) | Solyc05g013290 | 15 | 9 | 60 | 2 homo; 4 biallelic; 5 chimeric |
| Fls2.1 | Solyc02g070890 | 4 | 4 | 100 | 3 homo; 1 hetero |
| Fls3 | Solyc04g009640 | 11 | 7 | 64 | 5 homo; 2 hetero |
| LRRXII-1 | Solyc06g076910 | 5 | 1 | 20 | 1 biallelic |
| LRRXII-2 | Solyc04g012100 | 4 | 3 | 75 | 1 biallelic; 2 hetero |
| Mai1 | Solyc04g082260 | 4 | 1 | 25 | 1 hetero |
| Mai5 | Solyc10g085990 | 11 | 8 | 73 | 2 homo; 5 hetero; 1 chimeric |
| MAP3Ka | Solyc11g006000 | 6 | 6 | 100 | 4 biallelic; 2 hetero |
| Min7 | Solyc12g017830 | 5 | 4 | 80 | 1 biallelic; 1 hetero; 2 chimeric |
| MKK1 | Solyc12g009020 | 2 | 2 | 100 | 1 biallelic; 1 chimeric |
| MKK2 | Solyc03g123800 | 6 | 5 | 83 | 1 homo; 4 biallelic |
| MKK4 | Solyc03g097920 | 2 | 1 | 50 | 1 hetero |
| MKKK15 | Solyc02g065110 | 8 | 6 | 75 | 4 hetero; 2 chimeric |
| MKKK66 | Solyc08g081210 | 3 | 1 | 33 | 1 hetero |
| MLO16 | Solyc11g069220 | 4 | 4 | 100 | 1 biallelic; 2 hetero; 1 chimeric |
| NOD | Solyc11g008200 | 8 | 7 | 88 | 1 homo; 4 hetero; 2 chimeric |
| NPR1 | Solyc07g040690 | 5 | 1 | 20 | 1 hetero |
| NRC1/2/3 | Solyc01g090430 (NRC1) | 8 | 5 | 63 | 1 homo; 3 biallelic; 1 hetero |
| Solyc10g047320 (NRC2) | |||||
| Solyc05g009630 (NRC3) | |||||
| PAD4 | Solyc02g032850 | 7 | 1 | 14 | 1 biallelic |
| PBCP | Solyc03g116690 | 3 | 2 | 67 | 1 homo; 1 biallelic |
| PBL-T1 | Solyc09g007170 | 5 | 3 | 60 | 1 biallelic; 2 chimeric |
| PBL-T2 | Solyc01g067400 | 2 | 2 | 100 | 2 hetero |
| Peptide Transporter 3 | Solyc05g009500 | 4 | 3 | 75 | 1 biallelic; 1 hetero; 1 chimeric |
| Permease Transporter | Solyc03g005820 | 4 | 2 | 50 | 1 homo; 1 biallelic |
| PGA1 | Solyc05g005560 | 5 | 2 | 40 | 2 hetero |
| Solyc05g005570 | |||||
| Pic1 | Solyc07g066260 | 5 | 4 | 80 | 1 biallelic; 2 hetero; 1 chimeric |
| PR1b | Solyc00g174340 | 6 | 4 | 67 | 3 biallelic; 1 chimeric |
| Propep1 | Solyc04g072310 | 2 | 2 | 100 | 2 chimeric |
| RALF1 | Solyc01g067900 | 3 | 3 | 100 | 1 homo; 2 biallelic |
| RALF2 | Solyc01g099520 | 10 | 7 | 70 | 1 homo; 3 hetero; 3 chimeric |
| RbohB | Solyc03g117980 | 8 | 3 | 38 | 1 homo; 2 biallelic |
| SAG101-1/2 | Solyc02g069400 (SAG101-1) | 3 | 2 | 67 | 1 homo; 1 biallelic |
| Solyc02g067660 (SAG101-2) | |||||
| SlMlo1/9 | Solyc04g049090 (SlMlo1) | 10 | 9 | 90 | 1 homo; 2 biallelic; 3 hetero; 6 chimeric |
| Solyc06g010030 (SlMlo9) | |||||
| SOBIR/SOBIR-like | Solyc06g071810 (SOBIR) | 16 | 9 | 56 | 2 homo; 1 biallelic; 4 hetero; 3 chimeric |
| Solyc03g111800 (SOBIR-like) | |||||
| Solute Transporter 2 | Solyc05g005950 | 4 | 2 | 50 | 1 biallelic; 1 hetero |
| STP13 | Solyc09g075820 | 2 | 1 | 50 | 1 homo |
| TFT1 | Solyc11g010470 | 3 | 3 | 100 | 1 biallelic; 2 hetero |
| TFT10 | Solyc04g076060 | 4 | 2 | 50 | 2 chimeric |
| TFT7 | Solyc04g074230 | 2 | 2 | 100 | 2 hetero |
| Wak1 | Solyc09g014720 | 5 | 5 | 100 | 2 homo; 2 biallelic; 1 chimeric |
| WRKY11 | Solyc08g006320 | 2 | 2 | 100 | 2 chimeric |
| WRKY9b | Solyc08g067360 | 4 | 1 | 25 | 1 biallelic |
aMutation rate (%) = number of plants with mutations/number of total transgenic plants. Mutations were analyzed by Geneious R11 and TIDE. bHomo, homozygous mutation; hetero, heterozygous mutation. cThree gRNA cassettes were cloned into one p201N:Cas9 plasmid. dTomato genotype Hawaii 7981 was used for transformation. eTomato genotype RG-pto11 was used for transformation. fSpecific gRNA for each gene was independently cloned into the p201:Cas9 vector and the two or three gRNA/Cas9 constructs were pooled together for tomato transformation.
Examination of possible off-target mutations caused by 12 selected gRNAs in multiple generations. See also and .
| gRNAs | Putative off-target locus | Sequence of the putative off-target sitesa | Predicted by | No. of mismatches | No. of plants tested | No. of plants with mutations | |
|---|---|---|---|---|---|---|---|
|
| #1 | SL3.0ch00: 19,581,605 - 19,581,626 | gGAATCTG | Geneious | 2 | 30 (10 T1 + 20 T2) |
|
| #2 | SL3.0ch08: 52,560,219 - 52,560,240 | g | Geneious | 3 | 20 (10 T1 + 10 T2) |
| |
|
| #1 | SL3.0ch03: 56,335,989 - 56,336,010 (CDS) | gGTAT | Geneious/CasOFFinder | 3 | 2 (T0) |
|
| #2 | SL3.0ch03: 56,356,193 - 56,356,214 (CDS) | gGTAT | Geneious/CasOFFinder | 3 | 2 (T0) |
| |
|
| #1 | SL3.0ch11: 22,381,618 - 22,381,638 | gATGC | Geneious | 2 | 17 (10 T1 + 7 T2) |
|
|
| #1 | SL3.0ch05: 66,181,295 - 66,181,316 (CDS) | gTCTACGAATATATGCCA | Geneious/CasOFFinder | 1 | 1 (T0) |
|
|
| #1 | SL3.0ch09: 795,322 - 795,343 (CDS) | gT | Geneious/CasOFFinder | 1 | 3 (1 T0 + 2 T1) |
|
| #2 | SL3.0ch12: 67,901,371 - 67,901,392 (CDS) | gTA | Geneious | 3 | 3 (1 T0 + 2 T1) |
| |
| #3 | SL3.0ch12: 67,814,680 - 67,814,701 (CDS) | gTA | Geneious | 3 | 3 (1 T0 + 2 T1) |
| |
|
| #1 | SL3.0ch02: 16,695,145 - 16,695,165 | gAA | Geneious | 3 | 17 (2 T0 + 15 T1) |
|
|
| #1 | SL3.0ch02: 48,342,685 - 48,342,706 (intron) | G | Geneious | 3 | 15 (1 T0 + 7 T1 + 7 T2) |
|
|
| #1 | SL3.0ch11: 16,102,764 - 16,102,785 | gATG | Geneious | 3 | 4 (1 T0 + 3 T1) |
|
|
| #1 | SL3.0ch11: 42,841,387 - 42,841,409 | GTTG | Geneious | 3 | 5 (2 T1 + 3 T2) |
|
|
| #1 | SL3.0ch02: 31,876,612 - 31,876,633 | gT | Geneious | 3 | 11 (4 T1 + 7 T2) |
|
|
| #1 | SL3.0ch11: 42,990,626 - 42,990,647 (Intron) | gATTCACTG | Geneious/CasOFFinder | 2 | 7 (1 T0 + 6 T1) |
|
| #2 | SL3.0ch08: 34,312,506 - 34,312,527 (CDS) | g | Geneious | 4 | 7 (1 T0 + 6 T1) |
| |
|
| #1 | SL3.0ch11: 17,271,683 - 17,271,703 (Intron) | gAATGT | Geneious | 2 | 14 (1 T0 + 13 T1) |
|
| #2 | SL2.5chr03: 5,874,879-5,874,902 (CDS) | GAATGT | CasOFFinder | 3 | 14 (1 T0 + 13 T1) |
|
aThe PAM motif occurs at the 3’ end of each sequence (AGG, GGG, or TGG). Mismatched bases are in bold and underlined; “g” in lower case means the first nucleotide of the putative off-target sequence is not a “G” but was converted to that nucleotide to accommodate the transcription initiation requirement of the U6 promoter.
bThis is not a true off-target as it was intentionally designed to target a Mai5 homolog PBL-T1).
Figure 1Evaluation of gRNA-mediated mutation efficiency by agroinfiltration in tomato leaves. See also and . (A) Schematic showing the workflow of guide RNA (gRNA) evaluation by agroinfiltration. (B) Summary of gRNA efficiency tested by agroinfiltration. (C) The distribution of mutation efficiencies of the 195 gRNAs. Inset on the top right shows the number of gRNAs in each mutation efficiency range. TIDE (https://tide.deskgen.com) was used to calculate mutation efficiency by identifying the predominant types of insertions and deletions (indels) in the DNA of a targeted cell pool.
Figure 2CRISPR/Cas9-induced gene mutations in T0 transgenic plants. See also . (A) The average mutation rate induced by CRISPR/Cas9 in T0 plants. (B) Summary of CRISPR-induced mutation types and their frequency in T0 plants. Left: Number of genes modified with the corresponding mutation type; Right: Percentage of genes harboring the corresponding mutation type. a Some plants have multiple target genes in one plant. (C) Frequency of each insertion or deletion mutation. x-axis: number of base pairs (bp) deleted (−) or inserted (+) into target sites. Inset on the left top shows the percentage of mutations ≤10 bp or >10 bp. All “possible > ± 50 bp” in the figure are included in >10 bp. TIDE only calculates mutation length ≤50 bp. (D) Percentage of different bases in the 1-bp insertion mutations. Inset at the right top shows the number of mutations with each type of inserted base.
New genotypes detected in T1 or T2 plants.
| T0 mutation typea | Generation | Plants | Gene Solyc# | Mutationb | Is T-DNA present? |
|---|---|---|---|---|---|
|
|
|
|
|
|
|
| T1 | NRC2-E4-P2 | Solyc10g047320 | +1 bp/large deletion | No | |
| T2 | NRC2-E4-P2-2 | Solyc10g047320 | -265 bp/-265 bp | No | |
| T2 | NRC2-E4-P2-4 | Solyc10g047320 | +1 bp/+1bp | No | |
|
|
|
|
|
|
|
| T1 | Mai1-E10-P20 | Solyc04g082260 | +1 bp/WT | Yes | |
|
|
|
|
|
|
|
| T1 | CathepsinB2-E8-P2 | Solyc02g077040 | -2 bp/-2 bp | No | |
| T1 | CathepsinB2-E8-P10 | Solyc02g077040 | -1 bp/WT | No | |
|
|
|
|
|
|
|
| T1 | Min7-E6-P4 | Solyc12g017830 | +1 bp/-3 bp | Yes | |
| T1 | Min7-E6-P8 | Solyc12g017830 | -1 bp/WT | No | |
|
|
|
|
|
|
|
| T1 | NRC2-E1-P6 | Solyc10g047320 | -3 bp/-5 bp | Yes | |
| T1 | NRC2-E1-P15 | Solyc10g047320 | -3 bp (58%); -6 bp (32%) +1 bp (3.6%) | No | |
|
|
|
|
|
|
|
| T1 | MKKK15-E2-P2 | Solyc02g065110 | -5 bp(60%); -1 bp (31%); +1 bp (4.7%) | Yes | |
| T1 | MKKK15-E2-P3 | Solyc02g065110 | -5 bp (20%); WT (74%) | No | |
| T1 | MKKK15-E2-P7 | Solyc02g065110 | +1 bp (77.6%); -5 bp (4.7%); WT (9.5%) | Yes | |
|
|
|
|
|
|
|
| T1 | MKK1-E1-P3 | Solyc12g009020 | -2 bp/-4 bp | No | |
|
|
|
|
|
|
|
| T1 | Min7-E5-P1 | Solyc12g017830 | -1 bp/-3 bp | Yes | |
| T1 | Min7-E5-P2 | Solyc12g017830 | -6 bp (64.5%); +1 bp (19%); -1 bp (8.8%); | ||
| -7 bp (3.4%) | Yes | ||||
| T1 | Min7-E5-P3 | Solyc12g017830 | -5 bp/-6 bp | Yes | |
| T1 | Min7-E5-P7 | Solyc12g017830 | -9 bp (71.3%); +1 bp (18.2%); -1 bp (3.6%) | Yes | |
|
|
|
|
|
|
|
| T1 | ADE-E2-P1 | Solyc05g005700 | WT/WT | No | |
| T1 | ADE-E2-P20 | Solyc05g005700 | -4 bp/-9 bp | No |
aFor each mutant event, only the plants harboring different genotypes from their T0 progenitors are listed. Unlisted T1 or T2 progeny have the same genotypes as those in T0 plants.
bNumber of base pairs (bp) deleted (-) or inserted (+) into target sites; WT, wild-type. If no percentage is shown, the two genotypes are around 50%:50%.
cTIDE only detects indels ≤50 bp.
Figure 3Tomato transformation with “Agrobacterium pools.” See also . (A) An example of a tomato transformation experiment designed to target 2–4 genes by using 3–4 pooled Agrobacterium cultures with each culture carrying a different gRNA. a Number of plants with mutations in the target gene is shown in parentheses; some plants had mutations in multiple genes. b Number of genes modified in the plants. “na” not applicable, since less than 3 genes were targeted in the experiment. (B) Left: Number of gRNAs detected in a single mutant plant by PCR and Sanger sequencing. Right: Percentage of T0 plants harboring no, one or two gRNAs.